newsfilter
← Latest News
GlobeNewswire·

Topline Results from PALM 007 Study of SIGA's Tecovirimat in Treatment of Mpox Released

Preliminary analysis shows the study did not reach statistical significance on its primary endpoint of tecovirimat being superior to placebo in lesion resolution for all patientsResults suggest tecovirimat provides